INNATE PHARMA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.555 EUR | -2.85% |
|
+9.89% | -2.48% |
| May. 14 | Transcript : Innate Pharma S.A., Q1 2024 Earnings Call, May 14, 2024 | |
| Apr. 15 | Sanofi: progress in hematology trial | CF |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 2.630 | 2.760 | 2.920 |
| Spread/Res. | -2.85% | -7.43% | -12.50% |
| Spread/Supp. | +9.19% | +21.09% | +21.09% |
| Support | 2.340 | 2.110 | 2.110 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- IPH Stock
- Charts Innate Pharma